Carregant...
The Assessment of Non-Feminizing Estrogens for Use in Neuroprotection
The menopause is associated with a precipitous decline in circulating estrogens and a resulting loss of the neuroprotective actions of this steroid hormone. In view of the results of the Women’s Health Initiative and the preceding knowledge that orally administered estrogens has a variety of adverse...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3048764/ https://ncbi.nlm.nih.gov/pubmed/21111714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.brainres.2010.11.058 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|